| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |